BLACKTHORN THERAPEUTICS
BlackThorn Therapeutics operator of a clinical-stage biopharmaceutical company intended to develop precision medicine for disorders of the central nervous system (CNS) based on advances in computational and clinical neuroscience. The company leverages a deep understanding of brain and behavior relationships that seeks to overcome historic challenges in drug discovery and development by targeting dysfunctional brain circuits. Its proprietary computational platform, the company seeks to identify novel targets, small molecule drug candidates and biologically-based patient subgroups most likely to respond to treatment.
BLACKTHORN THERAPEUTICS
Industry:
Artificial Intelligence Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.blackthornrx.com
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
138 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Domain Not Resolving Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Homerun Smart
Homerun Smart is an independent research and development enterprise dedicated to artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
GV
GV investment in Series B - BlackThorn Therapeutics
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series B - BlackThorn Therapeutics
The Scripps Research Institute
The Scripps Research Institute investment in Series B - BlackThorn Therapeutics
Premier Partners
Premier Partners investment in Series B - BlackThorn Therapeutics
Vertex Ventures HC
Vertex Ventures HC investment in Series B - BlackThorn Therapeutics
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series B - BlackThorn Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - BlackThorn Therapeutics
Biomatics Capital Partners
Biomatics Capital Partners investment in Series B - BlackThorn Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - BlackThorn Therapeutics
Mercury
Mercury investment in Series B - BlackThorn Therapeutics
Official Site Inspections
http://www.blackthornrx.com
- Host name: 201.23.196.104.bc.googleusercontent.com
- IP address: 104.196.23.201
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "BlackThorn Therapeutics"
BlackThorn Therapeutics - Crunchbase Company …
Contact Email [email protected] BlackThorn Therapeutics operator of a clinical-stage biopharmaceutical company intended to develop precision medicine for disorders of the central nervous system (CNS) based on advances in …See details»
BlackThorn Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BlackThorn Therapeutics, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Blackthorn Therapeutics - PitchBook
Blackthorn Therapeutics General Information Description. Operator of a clinical-stage biopharmaceutical company intended to create precision medicine for disorders of the central …See details»
BlackThorn Therapeutics Company Overview, Contact Details
Jun 13, 2019 Blackthornrx hired William J. Martin as Board of Directors on Oct 21st '19. BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as Chief Executive Officer to Lead …See details»
BlackThorn Therapeutics - Craft
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company that uses a novel and robust platform (INFORMâ„¢) to link behavioral deficits with brain physiology to discover and …See details»
BlackThorn - Biomatics Capital
Jan 4, 2019 BlackThorn Therapeutics Announces Participation in Key Data Science and Cloud Computing Panels to Advance Therapeutic Development at 2018 BIO Investor ForumSee details»
BlackThorn Therapeutics Company Profile: , Investments, Contact ...
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) …See details»
BlackThorn Therapeutics Advances Phase 2 Clinical Development …
Jan 23, 2020 BlackThorn is headquartered in San Francisco, California. For more information, please visit blackthornrx.com. Reference: Krystal A, Neuropsychopharmacology 43, 1–76 (2018)See details»
BlackThorn Therapeutics - Contacts, Employees, Board Members, …
Organization. BlackThorn Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of …See details»
BlackThorn Therapeutics Announces Positive Phase 1 Results for …
Apr 1, 2019 — Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa Therapeutics 2019 Conference —See details»
BlackThorn Therapeutics Announces Positive Phase 1 Results
Apr 1, 2019 SAN FRANCISCO--(BUSINESS WIRE)-- BlackThorn Therapeutics, a neurobehavioral health company leveraging its proprietary computational psychiatry platform …See details»
BlackThorn Therapeutics - Company info. interviews, news
BlackThorn Therapeutics, Inc., is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence technologies to advance its pipeline of targeted …See details»
BlackThorn Therapeutics Initiates Phase 1 Study of BTRX
Jun 6, 2018 SAN FRANCISCO--(BUSINESS WIRE)-- BlackThorn Therapeutics, a clinical-stage biopharmaceutical company discovering and developing targeted treatments for …See details»
BlackThorn Therapeutics Reports Data Supporting Phase 2 …
Dec 11, 2019 SAN FRANCISCO--(BUSINESS WIRE)--BlackThorn Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing targeted medicines to treat central …See details»
BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as Chief ...
Oct 21, 2019 SAN FRANCISCO--(BUSINESS WIRE)--BlackThorn Therapeutics, Inc., today announced the promotion of company co-founder and seasoned CNS drug discovery and …See details»
BlackThorn Therapeutics Appoints William J. Martin, Ph.D
Oct 21, 2019 SAN FRANCISCO--(BUSINESS WIRE)-- BlackThorn Therapeutics, Inc., today announced the promotion of company co-founder and seasoned CNS drug discovery and …See details»
BlackThorn Therapeutics Announces R&D Updates - Business Wire
Jan 4, 2019 BTRX-335140 Poised to Enter Phase 2 Efficacy Studies and BTRX-323511 to Enter IND-enabling Studies. Company Increasing Investment in Computational Psychiatry …See details»
BlackThorn Therapeutics Announces Innovative Clinical …
Jun 7, 2017 The company is headquartered in South San Francisco, Calif. For more information, please visit www.blackthornrx.com. About Mindstrong Health, Inc. Mindstrong Health is …See details»
BlackThorn Therapeutics Advances Phase 2 Clinical ... - BioSpace
Jan 23, 2020 BlackThorn Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing targeted medicines to treat central nervous system (CNS) disorders, …See details»
BlackThorn Therapeutics Closes $76 Million Series B to Advance
Jun 13, 2019 For more information, please visit blackthornrx.com Contacts Laura Hansen, Ph.D., VP, Corporate Affairs BlackThorn Therapeutics [email protected] tel: …See details»